Effect of WR-2721 on the toxicity and antitumor activity of the combination of carboplatin and 5-fluorouracil

Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II

A. Hilary Calvert, S.J. Harland, David R. Newell et al. · Cancer Chemotherapy and Pharmacology · 1982 · 486 citations

Medicine, Medicinal Chemistry, Pharmacology +5

Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells.

Kevin J. Scanlon, Edward M. Newman, Yuzhi Lu et al. · Proceedings of the National Academy of Sciences · 1986 · 369 citations

Medicine, Oncology, Pharmacology +16

Radiation sensitizers

Theodore L. Phillips · International Journal of Radiation Oncology*Biology*Physics · 1979 · 208 citations

A randomized trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck

Julie A. Kish, John F. Ensley, Arthur Weaver et al. · Cancer · 1985 · 166 citations · Full text

Medicine, Oncology, Chemotherapy +8

Selective inhibition of the nephrotoxicity of cis-dichlorodiammineplatinum(II) by WR-2721 without altering its antitumor properties.

Yuhas Jm, Filip Čulo · PubMed · 1980 · 144 citations

Medicine, Oncology, Pharmacology +14